| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |